Cargando…
Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors
New thymol − 1,5-disubstitutedpyrazole hybrids were synthesised as dual COX-2/5-LOX inhibitors. Compounds 8b, 8g, 8c, and 4a displayed in vitro inhibitory activity against COX-2 (IC(50 )= 0.043, 0.045, 0.063, and 0.068 µM) nearly equal to celecoxib (IC(50 )= 0.045 µM) with high SI (316, 268, 204, an...
Autores principales: | El-Miligy, Mostafa M. M., Al-Kubeisi, Ahmed K., Bekhit, Mohamed G., El-Zemity, Saad R., Nassra, Rasha A., Hazzaa, Aly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704104/ https://www.ncbi.nlm.nih.gov/pubmed/36408833 http://dx.doi.org/10.1080/14756366.2022.2147164 |
Ejemplares similares
-
Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018) -
Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor
por: Athira, A. P., et al.
Publicado: (2013) -
Utility of novel 2-furanones in synthesis of other heterocyclic compounds having anti-inflammatory activity with dual COX2/LOX inhibition
por: Abd El-Hameed, Rania H., et al.
Publicado: (2021) -
A Metabolomic Approach to Target Compounds from the Asteraceae Family for Dual COX and LOX Inhibition
por: Chagas-Paula, Daniela A., et al.
Publicado: (2015) -
Evidence for using a dual COX 1/2 and 5-LOX inhibitor in neurodegenerative diseases
por: Irrera, Natasha, et al.
Publicado: (2017)